Intelligence · Clinical pipeline
Infectious disease · Phase III
Infectious disease programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Infectious disease Phase III programs: NovaPharmaNews indexes 301 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- United Therapeutics Europe 22 programs
- GSK Glaxo Smith 20 programs
- BRIGHT MINDS BIOSCIENCES 18 programs
- Chinese Academy of 13 programs
- Takeda 12 programs
- Sinovac Research and 11 programs
- Gilead Sciences Ireland 10 programs
- PARItec 10 programs
- Gilead Sciences 9 programs
- Pfizer 8 programs
- Vir Biotechnology 7 programs
- George Institute for 6 programs
Pipeline programs
-
interferon alfa
Ultragenyx UK Limited
Hepatitis C
1 trial -
mRNA1647-P301
Moderna Biotech Spain
Cytomegalovirus Infection (CMV)
1 trial -
maribavir
Takeda
Cytomegalovirus Infections
2 trials -
mavrilimumab
Kiniksa Pharmaceuticals International, plc
COVID
1 trial -
methadone
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
peginterferon alfa-2a
Hoffmann-La Roche
Hepatitis C, Chronic
2 trials -
peginterferon alfa-2b (SCH 54031)
Universal Integrated
Hepatitis C, Chronic
1 trial -
probiotic strain Bb-12
United Therapeutics Europe Ltd
Infections, Respiratory
1 trial -
sotrovimab
Vir Biotechnology
Covid19
3 trials -
strengths-based case management
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
telbivudine or lamivudine
Novartis Pharmaceuticals
Chronic Hepatitis B
1 trial -
tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer
Community-Acquired Infections
1 trial -
vitamin D
Takeda
COVID-19
1 trial
Frequently asked questions
How many infectious disease Phase III programs exist?
301 programs match both the therapeutic area and stage filters in our published index.